TANG CAPITAL MANAGEMENT LLC

CIK 1232621 · last filed 2026-07-21

TANG CAPITAL MANAGEMENT LLC is a corporate insider who has filed 53 SEC Form 4 insider transactions across 15 companies since 2008. The most recent filing shows the insider bought $23.7K of BOLD on Jul 21, 2026. Across all open-market trades the lifetime net is +$170.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $241.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$241.09M

Companies

15

Total Filings

53

Lifetime Open-Market Net

$170.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLD 10%+ Owner 2,858,935 $2.47 $7.06M $3.03M 6 2026-07-21
FULC 10%+ Owner 7,030,000 $3.72 $26.15M $2.97M 2 2026-07-20
AUPH 10%+ Owner 12,838,002 $14.96 $192.06M $24.91M 1 2026-06-02
TCR2 THERAPEUTICS INC. (TCRR) Delisted 10%+ Owner 4,394,800 $1.48 $6.50M $1.90M 2 2023-05-30
Odonate Therapeutics, Inc. (ODT) Delisted 10%+ Owner 15,045,717 $1.12 $16.85M $77.61M 7 2021-11-19
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted 10%+ Owner 9,194,673 $6.22 $57.19M $41.28M 7 2020-09-09
Bio Green Med Solution, Inc. (CYCCP) Delisted 10%+ Owner 559,900 $5.05 $2.83M $1.75M 1 2017-02-27
Ardea Biosciences, Inc./DE (RDEA) Delisted 10%+ Owner 3,748,671 $21.75M 2 2012-02-03
HERON THERAPEUTICS, INC. /DE/ (APPA) Delisted 10%+ Owner 16,496 $10.71M 5 2009-10-21
VNDA 10%+ Owner 3,065,852 $5.16 $15.82M -$20.62M 4 2009-10-15
PENWEST PHARMACEUTICALS CO (PPCO) Delisted 10%+ Owner 6,392,498 $204.4K 2 2009-03-13
ARADIGM CORP (ARDM) Delisted 10%+ Owner 13,500 $0 1 2008-11-12
NEOSE TECHNOLOGIES INC (NTEC) Delisted 10%+ Owner 10,251,914 $9.63 $98.73M $951.9K 2 2008-09-24
Molecular Templates, Inc. (THLDD) Delisted 10%+ Owner 54,231 $4.50M 1 2008-09-03
TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted 10%+ Owner 1,118,047 -$269.3K 1 2008-02-20

Recent Filings

53 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-21 BOLD Buy (P) +9,726 $23.7K EDGAR
2026-07-20 FULC Buy (P) +335,232 $1.19M EDGAR
2026-07-16 BOLD Buy (P) +127,938 $311.3K EDGAR
2026-07-15 FULC Buy (P) +499,892 $1.78M EDGAR
2026-07-13 BOLD Buy (P) +183,170 $444.1K EDGAR
2026-07-08 BOLD Buy (P) +114,420 $283.7K EDGAR
2026-07-02 BOLD Buy (P) +214,926 $537.8K EDGAR
2026-06-29 BOLD Buy (P) +572,666 $1.43M EDGAR
2026-06-02 AUPH Mixed +1,629,212 $24.91M EDGAR
2025-02-27 Disp (D) −1,116,000 $0
Showing 110 of 53
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.